Tweet
Antimicrob Agents Chemother. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy
[Source: Antimicrobial Agents Chemotherapy, full page: (LINK). Abstract, edited.]
Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy
Naoyuki Miyashita 1, Hiroto Akaike 2, Hideto Teranishi 2, Kazunobu Ouchi 2 and Niro Okimoto 1
Author Affiliations: <SUP>1</SUP>Department of Pediatrics <SUP>2</SUP>Department of Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
ABSTRACT
We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (p = 0.0361 and p = 0.0237, respectively).
FOOTNOTES
Address correspondence to: Naoyuki Miyashita, MD, PhD, Department of Internal Medicine 1, Kawasaki Medical School, 2-1-80 Nakasange, Kita-ku, Okayama City, Okayama 700-8505, Japan, TEL: +81-86-225-2111 FAX: +81-86-232-8343, E-mail: nao@med.kawasaki-m.ac.jp
Copyright ? 2013, American Society for Microbiology. All Rights Reserved.
-
-------
Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy
Naoyuki Miyashita 1, Hiroto Akaike 2, Hideto Teranishi 2, Kazunobu Ouchi 2 and Niro Okimoto 1
Author Affiliations: <SUP>1</SUP>Department of Pediatrics <SUP>2</SUP>Department of Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
ABSTRACT
We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (p = 0.0361 and p = 0.0237, respectively).
FOOTNOTES
Address correspondence to: Naoyuki Miyashita, MD, PhD, Department of Internal Medicine 1, Kawasaki Medical School, 2-1-80 Nakasange, Kita-ku, Okayama City, Okayama 700-8505, Japan, TEL: +81-86-225-2111 FAX: +81-86-232-8343, E-mail: nao@med.kawasaki-m.ac.jp
Copyright ? 2013, American Society for Microbiology. All Rights Reserved.
-
-------